Single cell multiomic profiling of human lung reveals cell type-specific and age-dynamic control of SARS-CoV2 host genes

  1. Allen Wang  Is a corresponding author
  2. Joshua Chiou
  3. Olivier B Poirion
  4. Justin Buchanan
  5. Michael J Valdez
  6. Jamie M Verheyden
  7. Xiaomeng Hou
  8. Parul Kudtarkar
  9. Sharvari Narendra
  10. Jacklyn M Newsome
  11. Minzhe Guo
  12. Dina A Faddah
  13. Kai Zhang
  14. Randee E Young
  15. Justinn Barr
  16. Eniko Sajti
  17. Ravi Misra
  18. Heidie Huyck
  19. Lisa Rogers
  20. Cory Poole
  21. Jeffery A Whitsett
  22. Gloria Pryhuber
  23. Yan Xu
  24. Kyle J Gaulton  Is a corresponding author
  25. Sebastian Preissl  Is a corresponding author
  26. Xin Sun  Is a corresponding author
  27. NHLBI LungMap Consortium
  1. University of California, San Diego, United States
  2. Cincinnati Children's Hospital Medical Center/University of Cincinnati College of Medicine, United States
  3. Vertex Pharmaceuticals, United States
  4. Ludwig Institute for Cancer Research, United States
  5. University of Rochester Medical Center, United States
  6. Cincinnati Children's Hospital Medical Center, United States
  7. CCHMC/University of Cincinnati, United States

Abstract

Respiratory failure associated with COVID-19 has placed focus on the lung. Here, we present single-nucleus accessible chromatin profiles of 90,980 nuclei and matched single-nucleus transcriptomes of 46,500 nuclei in non-diseased lung from donors of ~30 weeks gestation, ~3 years and ~30 years. We mapped candidate cis-regulatory elements (cCREs) and linked them to putative target genes. We identified distal cCREs with age-increased activity linked to SARS-CoV-2 host entry gene TMPRSS2 in alveolar type 2 cells which had immune regulatory signatures and harbored variants associated with respiratory traits. At the 3p21.31 COVID-19 risk locus, a candidate variant overlapped a distal cCRE linked to SLC6A20, a gene expressed in alveolar cells and with known functional association with the SARS-CoV-2 receptor ACE2. Our findings provide insight into regulatory logic underlying genes implicated in COVID-19 in individual lung cell types across age. More broadly, these datasets will facilitate interpretation of risk loci for lung diseases.

Data availability

Processed data including the full list of peaks are available for download and can be explored using the web portal www.lungepigenome.org. Raw sequencing files has been submitted to LungMap Data Collecting Core and will be submitted to dbGAP.Source data for Figure 1 - figure supplement 1 is available as Supplementary Table 2; Source data for Figure 3B and Figure 3 - figure supplement 1A is available as Supplementary Table 3. Source data for Figure 3E is available as Supplementary Table 4. Source data for Figure 3F is available as Supplementary Table 5. Source data for Figure 3G is available as Supplementary Table 6.Source data for Figure 4A is available as Supplementary Table 7.

Article and author information

Author details

  1. Allen Wang

    Department of Pediatrics and Cellular and Molecular Medicine, University of California, San Diego, La Jolla, United States
    For correspondence
    a5wang@ucsd.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9870-7888
  2. Joshua Chiou

    Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4618-0647
  3. Olivier B Poirion

    Cellular and Molecular Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  4. Justin Buchanan

    Cellular and Molecular Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  5. Michael J Valdez

    Pediatrics, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  6. Jamie M Verheyden

    Pediatrics, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  7. Xiaomeng Hou

    Cellular and Molecular Medicine, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  8. Parul Kudtarkar

    Pediatrics, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  9. Sharvari Narendra

    Pediatrics, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  10. Jacklyn M Newsome

    Department of Pediatrics, Rady Children's Hospital, Division of Genome Information Sciences, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  11. Minzhe Guo

    Division of Neonatology, Perinatal and Pulmonary/Divisions of Pulmonary Biology and Biomedical Informatics Biology/, Cincinnati Children's Hospital Medical Center/University of Cincinnati College of Medicine, Cincinnati, United States
    Competing interests
    No competing interests declared.
  12. Dina A Faddah

    Vertex Pharmaceuticals, Vertex Pharmaceuticals, San Diego, United States
    Competing interests
    No competing interests declared.
  13. Kai Zhang

    Ludwig Institute for Cancer Research, La Jolla, United States
    Competing interests
    No competing interests declared.
  14. Randee E Young

    Pediatrics, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  15. Justinn Barr

    Pediatrics, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  16. Eniko Sajti

    Pediatrics, University of California, San Diego, La Jolla, United States
    Competing interests
    No competing interests declared.
  17. Ravi Misra

    Pediatrics, University of Rochester Medical Center, Rochester, United States
    Competing interests
    No competing interests declared.
  18. Heidie Huyck

    Pediatrics, University of Rochester Medical Center, Rochester, United States
    Competing interests
    No competing interests declared.
  19. Lisa Rogers

    Pediatrics, University of Rochester Medical Center, Rochester, United States
    Competing interests
    No competing interests declared.
  20. Cory Poole

    Pediatrics, University of Rochester Medical Center, Rochester, United States
    Competing interests
    No competing interests declared.
  21. Jeffery A Whitsett

    Cincinnati Children's Hospital Medical Center, Cincinnati, United States
    Competing interests
    No competing interests declared.
  22. Gloria Pryhuber

    Pediatrics, University of Rochester Medical Center, Rochester, United States
    Competing interests
    No competing interests declared.
  23. Yan Xu

    Division of Neonatology, Perinatal and Pulmonary/Divisions of Pulmonary Biology and Biomedical Informatics Biology, CCHMC/University of Cincinnati, Cincinnati, United States
    Competing interests
    No competing interests declared.
  24. Kyle J Gaulton

    Department of Pediatrics, University of California, San Diego, La Jolla, United States
    For correspondence
    kgaulton@health.ucsd.edu
    Competing interests
    Kyle J Gaulton, KJG does consulting for Genentech, DAF is an employee and holds stock in Vertex Pharmaceuticals.
  25. Sebastian Preissl

    Cellular and Molecular Medicine, University of California, San Diego, La Jolla, United States
    For correspondence
    spreissl@health.ucsd.edu
    Competing interests
    No competing interests declared.
  26. Xin Sun

    Pediatrics, University of California, San Diego, La Jolla, United States
    For correspondence
    xinsun@health.ucsd.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8387-4966
  27. NHLBI LungMap Consortium

Funding

National Heart, Lung, and Blood Institute (1U01HL148867)

  • Allen Wang
  • Jamie M Verheyden
  • Sebastian Preissl
  • Xin Sun

National Heart, Lung, and Blood Institute (U01HL122700)

  • Gloria Pryhuber

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Wang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 11,808
    views
  • 1,156
    downloads
  • 139
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Allen Wang
  2. Joshua Chiou
  3. Olivier B Poirion
  4. Justin Buchanan
  5. Michael J Valdez
  6. Jamie M Verheyden
  7. Xiaomeng Hou
  8. Parul Kudtarkar
  9. Sharvari Narendra
  10. Jacklyn M Newsome
  11. Minzhe Guo
  12. Dina A Faddah
  13. Kai Zhang
  14. Randee E Young
  15. Justinn Barr
  16. Eniko Sajti
  17. Ravi Misra
  18. Heidie Huyck
  19. Lisa Rogers
  20. Cory Poole
  21. Jeffery A Whitsett
  22. Gloria Pryhuber
  23. Yan Xu
  24. Kyle J Gaulton
  25. Sebastian Preissl
  26. Xin Sun
  27. NHLBI LungMap Consortium
(2020)
Single cell multiomic profiling of human lung reveals cell type-specific and age-dynamic control of SARS-CoV2 host genes
eLife 9:e62522.
https://doi.org/10.7554/eLife.62522

Share this article

https://doi.org/10.7554/eLife.62522

Further reading

    1. Developmental Biology
    2. Genetics and Genomics
    Anne-Sophie Pepin, Patrycja A Jazwiec ... Sarah Kimmins
    Research Article Updated

    Paternal obesity has been implicated in adult-onset metabolic disease in offspring. However, the molecular mechanisms driving these paternal effects and the developmental processes involved remain poorly understood. One underexplored possibility is the role of paternally induced effects on placenta development and function. To address this, we investigated paternal high-fat diet-induced obesity in relation to sperm histone H3 lysine 4 tri-methylation signatures, the placenta transcriptome, and cellular composition. C57BL6/J male mice were fed either a control or high-fat diet for 10 weeks beginning at 6 weeks of age. Males were timed-mated with control-fed C57BL6/J females to generate pregnancies, followed by collection of sperm, and placentas at embryonic day (E)14.5. Chromatin immunoprecipitation targeting histone H3 lysine 4 tri-methylation (H3K4me3) followed by sequencing (ChIP-seq) was performed on sperm to define obesity-associated changes in enrichment. Paternal obesity corresponded with altered sperm H3K4me3 at promoters of genes involved in metabolism and development. Notably, altered sperm H3K4me3 was also localized at placental enhancers. Bulk RNA-sequencing on placentas revealed paternal obesity-associated sex-specific changes in expression of genes involved in hypoxic processes such as angiogenesis, nutrient transport, and imprinted genes, with a subset of de-regulated genes showing changes in H3K4me3 in sperm at corresponding promoters. Paternal obesity was also linked to impaired placenta development; specifically, a deconvolution analysis revealed altered trophoblast cell lineage specification. These findings implicate paternal obesity effects on placenta development and function as one potential developmental route to offspring metabolic disease.

    1. Developmental Biology
    Emily Delgouffe, Samuel Madureira Silva ... Ellen Goossens
    Research Article

    Although the impact of gender-affirming hormone therapy (GAHT) on spermatogenesis in trans women has already been studied, data on its precise effects on the testicular environment is poor. Therefore, this study aimed to characterize, through histological and transcriptomic analysis, the spermatogonial stem cell niche of 106 trans women who underwent standardized GAHT, comprising estrogens and cyproterone acetate. A partial dedifferentiation of Sertoli cells was observed, marked by the co-expression of androgen receptor and anti-Müllerian hormone which mirrors the situation in peripubertal boys. The Leydig cells also exhibited a distribution analogous to peripubertal tissue, accompanied by a reduced insulin-like factor 3 expression. Although most peritubular myoid cells expressed alpha-smooth muscle actin 2, the expression pattern was disturbed. Besides this, fibrosis was particularly evident in the tubular wall and the lumen was collapsing in most participants. A spermatogenic arrest was also observed in all participants. The transcriptomic profile of transgender tissue confirmed a loss of mature characteristics - a partial rejuvenation - of the spermatogonial stem cell niche and, in addition, detected inflammation processes occurring in the samples. The present study shows that GAHT changes the spermatogonial stem cell niche by partially rejuvenating the somatic cells and inducing fibrotic processes. These findings are important to further understand how estrogens and testosterone suppression affect the testis environment, and in the case of orchidectomized testes as medical waste material, their potential use in research.